SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #327CAS 1区Top JournalHybrid

Clinical Cancer Research

Abbreviation (ISO):CLIN CANCER RES
Country: United States•WoS SCIE Quartile: Q1•Scopus SJR: 4.751•SCImago Rank: #327•Identifier (ISSN):1078-0432(Print)/1557-3265(Online)•Articles / Year: 642•Estimated Publication Fee (APC): $4,417 USD
Clarivate IF (2026)Q1
10.9
↑ +0.7

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
292

292 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
642articles/year
36.57% Gold OA•93.69% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 10.9)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.9)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.2)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 10)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 11.5)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 13.801)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 12.531)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.107)
🔵 Computed
20193.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.911)
🔵 Computed
20183.00đ
WoS Q1 có IF ≥ 5.0(IF: 10.199)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Clinical Cancer Research publishes innovative clinical and translational cancer research studies that bridge the laboratory and the clinic. The Journal is especially interested in clinical trials evaluating new treatments, accompanied by research on pharmacology, and molecular alterations or biomarkers that predict response or resistance to treatment. The Journal also prioritizes laboratory and animal studies of new drugs and molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. Specific areas of interest include clinical and translational research in targeted therapies; mechanisms of drug sensitivity and resistance; pharmacogenetics and pharmacogenomics; personalized medicine; novel applications of bioinformatics and biostatistics; immunotherapy and clinical immunology; gene therapy; radiobiology and radiation oncology; large-scale molecular characterization of human tumors; diagnostic biomarkers; innovative imaging and other novel methods with potential applicability to clinical investigation; clinical genetics; and detection of minimal disease.

Topics Covered (Recognized by AI)
Medicine96.7%Biology96.4%Genetics94.3%Internal medicine92.5%Chemistry77.7%Cancer73.7%Biochemistry71.7%Cancer research62.3%Pathology54.7%Gene45.3%Immunology43.1%Oncology39.9%Surgery35.7%Cell biology22.4%Chemotherapy20.6%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #327Scopus Q1SCImago Profile
Scopus Coverage:1995-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
4.751

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
405

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
9.26

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,417 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations16,520
3-Year Documents1,692
Citable Documents1,633

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
OncologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
American Association for Cancer Research Inc.
Publication Language
English
Frequency
Semimonthly
Founding Year
1995
Editorial Address
AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ONCOLOGY
JCRSCIE
33/333Q1
ONCOLOGY
JCISCIE
25/333Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—2,587577
202510.22,7613,964
2024108748,657
202311.566814,833
202213.80174823,647
202112.5311,05937,417
202010.1071,48251,793
20198.91192266,765
201810.1991,27270,415
2017—1,04472,292
2016—1,15483,892
2015—1,14676,673
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Clinical Cancer Research

WoS Q1
6913162018201920202021202220232024202510.20
Annual Impact Factor Metric
2025:10.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

ESMO Open
IF: 10.6Q1
100% MatchExplore →
Liver Cancer
IF: 10.5Q1
100% MatchExplore →
Record UUID: 02e3b388-fef6-4b98-9674-3d811e01130d
Database Updated: 2026-10-01